SCHEMBL29378024

SCHEMBL29378024

Brc1cnn(-c2cccc(N3CCCC3)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 4/20 0.41
DRD2 P14416 3/20 0.41
DRD3 P35462 3/20 0.41
DHFR P00374 1/20 0.41
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
KMT2A Q03164 1/20 0.41
HSD17B10 Q99714 1/20 0.41
APP P05067 1/20 0.40
AGXT P21549 1/20 0.39
PRMT6 Q96LA8 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
TERT O14746 1/20 0.37
HTR2C P28335 1/20 0.36
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22466068 1.00 DRD4 (0.41) DRD4DRD2DRD3DHFRKDM4E
SCHEMBL22466256 0.98 DRD4 (0.40) DRD4DRD2DRD3DHFRKDM4E
SCHEMBL22138020 0.88 ADRA2C (0.51) KDM4EMEN1GAAKMT2AAGXT
SCHEMBL22466056 0.87 DHFR (0.49) DRD4DRD2DRD3DHFRMEN1
SCHEMBL22466086 0.83 MELK (0.47) DRD4DRD2DRD3KDM4EMEN1
SCHEMBL22465940 0.82 MELK (0.46) DRD4DRD2DRD3KDM4EMEN1
SCHEMBL19541565 0.76 MELK (0.44) KDM4EMEN1ALDH1A1GAAHPGD
SCHEMBL22118578 0.76 EPHX2 (0.49) DRD2DRD3MEN1ALDH1A1GAA
SCHEMBL29434935 0.76 EPHX2 (0.49) DRD2DRD3MEN1ALDH1A1GAA
SCHEMBL30782532 0.76 NOTUM (0.47) KDM4EMEN1ALDH1A1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114025847-B Compounds and compositions as modulators of TLR signaling 神经孔疗法股份有限公司 2024-05-24 CN disclosed
EP-3946599-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING Neuropore Therapies, Inc. (US) 2022-02-09 EP disclosed
CN-114025847-A Compounds and compositions as modulators of TLR signaling 神经孔疗法股份有限公司 2022-02-08 CN disclosed